SARS-Cov-2 (Covid-19)

Our Covid-19 Story

We Are All In This Together

We were all pretty much going about our “business” prior to March 2020 when the pandemic struck. My first reaction was shock. Is this really happening? And when New York’s cases started sky-rocketing, I knew this was REAL SERIOUS, and I had to do something.

Hi, my name is Joseph Conroy and my background is Environmental Science with a focus on developing and applying AI and sensors to toxic air-borne contaminants. I have over 20 years of experience, and the DOE & EPA have awarded my companies over $ 500,000 in research grants.

My career began 20 years ago, when my team and I developed an atmospheric gas analyzer using advanced sensor technology and AI, that could identify specific toxic gases at the parts per billion level. This capability was an industry first, and helped reduce the Chlorine dioxide in the rivers (and fish) of the United States.

In developing this gas analyzer (Envair 2000), we also had to develop; (a) 120MB SSD hard-drive, (b) how to run advanced AI algorithms on a 486DX processor, and (C)  and transmit the data wirelessly using 1.5Ghz radio frequency at 1.5Mbps. In 2020, these specs are not a big-deal; but in 1999?

When my team and I started out, we had no idea that we would have to develop all of these secondary technologies, in order to achieve our primary goal. We just knew that we were focused on a specific goal, and as obstacles arose, we addressed them and kept moving forward.

Since 1999, my team and I have gone onto build and optimize many processes saving the US industry millions of dollars and simultaneously reducing the environmental impacts. Our work and technology improved the operation of power plants, power grids, wastewater treatment facilities, and even aircraft turbine blades.

Please forgive me if this sounds like I am taking a lame victory lap at your time and expense. I am not. I am simply trying to quickly share with you that my team and I have taken on many projects and succeeded at most of them.

New Project: SARS-Cov 2 & The Restaurant Industry

As the pandemic has unfolded across the US and the World, it has become very clear that there are 2 main impacts of this virus; (a) health, and (b) economic. When I started looking at which industries were being impacted the most, the restaurant industry quickly surfaced.

As you are probably already aware, there are over 1,000,000 restaurants in the US, employing 16.5 million people, with 70% of them being a single location.

When you consider that each employee on average has 1.75 family/household members, the industry number grows to 28.87 million Americans financially impacted by the pandemic . In comparison there are 1.7 million employed in the Automobile industry, and 8.3 million in the hotel industry.

Meanwhile, the CDC & NIH are telling us that even with a vaccine, this virus (and potentially future viruses) are not going away. Restaurants, for the most part, are an indoor activity. There has to be some type of indoor “virus sanitizer” that will scrub the air and enable restaurants to safely house its customers indoors while they dine.

Given these facts, I and my team began researching and analyzing all of the scientific data we could find about the SARS-CoV viruses at the Centers for Disease Control (CDC) and the National Institutes of Health (NIH). From this research we found (3) specific lab analysis’ at the NIH which focused on the deactivation and elimination of these viruses.

We took each of these lab tests completely apart, examining each and every step. Here we wanted to completely understand the process, the science, and rationale. As part of this process we reviewed all of the reference data (bibliography) too.

And finally, we researched what the industry was producing/developing for products that were focused on the interior elimination of this virus. Here, we wanted to understand how they were approaching the application scientifically, and how were they producing the product from a usability and ergonomic perspective.

From our analysis, we learned that the competition did not incorporate the specific science of the NIH into the design of their products.

For this pandemic application, I have set up a new company called Innovita specifically focused on it. 

Employing our own 20-years of artificial intelligence and sensor technologies, we have designed four (4) Covid-19 sterilization embodiments. For example, the PRVS-4000 portable room sterilizer is designed and its performance is based on the best science and lab performance tests that the Centers For Disease Control (CDC) and the National Institute of Health (NIH) have produced.

As of December 2020, InnoVita’s SARS-Cov-2 sterilization performance is 645% above the NIH laboratory tests which resulted in a “deactivation” (i.e. elimination) of 99.99% of any Corona type virus.

We have developed four versions of the sterilization technology which utilizes Ultraviolet light. The four technology embodiments are

  • Table Top (Portable, Battery Powered)
  • Portable Room (Portable, High Capacity)
  • Inline Ductwork (Fits existing ductwork dimensions)
  • Personal (Battery powered, sterilized air inhaler)

Please see our product pages for more info. And if you want to learn more about the science behind the products, click here.

InnoVita’s Team

Ramin Abrishamian

Ramin Abrishamian Chief Executive Officer

30 years of operational experience developing new technologies, commercializing them and growing companies based on them.

Joseph Conroy

Joseph Conroy Chief Technology Officer

20 year advanced sensor and AI technology visionary and architect. Joe has already filed 2 of 5 patents in advanced sensors and AI technology for the SARS-CoV-2 virus.

Carl Bomgardner

Carl Bomgardner AI & Software Director

40 year career of leading cutting edge AI and software technology development for Fortune 50 companies and startups.

Our Clients

jconroy11Our Story